Owkin

Owkin

TechBio

Series B – $230M raised

Created in 2016

201-500 employees including 11-20 in the USA

Understanding complex biology through AI

Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biological Artificial Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software. At the heart of this system is Owkin K, an AI copilot and its new LLM fine-tuned on biology called Owkin Zero, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster.

CONTACT INFORMATION

Dinesh Divakaran

VP, Business Development

New York, NY, USA

dinesh.divakaran@owkin.com

LinkedIn

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *